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  Diabetes mellitus is a chronic metabolic disease that develops mainly due to 
insulin deficiency or resistance to insulin action. All forms of diabetes are 
characterized by chronic hyperglycemia, which has an important role in the 
pathogenesis of diabetic complications. Leaves of Smallanthus sonchifolius 
(Poepp.&Endl.) H. Robinson (yacon) have been used since ancient times to prepare 
medicinal herbal tea with beneficial health properties. This review aims to discuss 
some key aspects related to the potential use of S. sonchifolius leaves and their 
natural biomolecules for the prophylaxis and treatment of diabetes as well as the 
potential mechanisms of action. 
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INTRODUCTION 
Diabetes mellitus is a group of metabolic 
disorders resulting from a defect in insulin secretion, 
insulin action or both which causes disturbances of 
carbohydrates, fat and protein metabolism (ADA 2009; 
Patel et al.,2012). There are three main types of diabetes, 
namely type 1 diabetes (juvenile diabetes), type 2 
diabetes and gestational diabetes. In type 1 diabetes, the 
β-cells of the pancreas do not make sufficient insulin. 
Type 2 diabetes is the major form of diabetes, accounting 
for approximately 90–95% of all diabetic cases. This 
form of diabetes usually begins with insulin insensitivity, 
a condition in which muscle, liver and fat cells do not 
respond to insulin properly. The pancreas eventually 
loses the ability to produce and secrete enough insulin in 
response to food intake. Gestational diabetes is caused by 
hormonal changes during pregnancy or by insulin 
insufficiency. Glucose in the blood fails to enter cells, 
thereby increasing the glucose level in the blood (Hui et 
al.,2009). 
The long-term diabetes is associated with the 
occurrence of complications that reduced quality of life 
and increased risk factors for mortality and morbidity 
(Strojek 2003). Hyperglycemia is a common effect of 
uncontrolled diabetes and long-term is an important step 
in the development and progression of serious damage in 
different body systems, especially the nerves and blood 
vessels. These alterations are divided into two types.”. 
Micro vascular complications include eye disease, 
kidney disease and neural damage which are commonly 
named as retinopathy, nephropathy and neuropathy 
respectively (Forbes and Cooper, 2013). Macro vascular 
complications include accelerated cardiovascular disease 
resulting in myocardial infarction and cerebrovascular 
disease manifesting as strokes (Luscher and Steffel 2008; 
Beckman et al., 2013; Paneni et al., 2013). Diabetic 
retinopathy and cardiovascular disease are one among 
the leading causes of blindness and deaths, respectively. 
The disease is associated with reduced quality of life and 
increased risk factors for mortality and morbidity. 
Diabetes mellitus is a common condition that 
affects people on both developed and developing 
countries.  The World Health Organization estimates that 
almost 3 million deaths occurring annually are as a result 
of diabetes (WHO 2002) and is a major and growing 
public health problem throughout the world. Globally, 
382 million people were detected with diabetes in 2013, 
and the number is expected to project to 592 million by 
2035 (Diabetes Atlas 2014). This worldwide epidemic of 
diabetes has been stimulating the search for new 
concepts and targets for the treatment of this incurable 
but controllable disease.  
Conventional drugs used in diabetes treatment 
attempt to improve insulin sensitivity, increase insulin 
production and / or decrease the amount of glucose in the 
blood. However, in addition to the possible adverse 
effects, the existing synthetic drugs have several 
limitations (Arumugam et al.,2013). Pharmacological 
treatments do not always succeed in maintaining normal 
blood glucose levels and avoid long-term consequences 
of diabetes (Prabhakar and Doble 2011).   It became 
imperative to discover and develop newer, safer and 
effective antidiabetic therapeutics which will not only 
control diabetes but also its associated complications 
(Sridhar et al., 2014).  Therefore, it is prudent to look for 
options in herbal medicines for diabetes as well. 
This review aims to discuss some key aspects 
related to the potential use one of the species of the 
genus Smallanthus, S. sonchifolius, and their natural 
biomolecules for the prophylaxis and treatment of 
diabetes as well as the potential mechanisms of action. 
Medicinal plants with potential antidiabetic activity 
Natural products are the major mine for 
discovering promising lead candidates, which play an 
important role in future drug development programs. 
Medicinal plants have been an integral part of 
human healthcare systems for centuries. They have been 
used either in the form of pure phytochemicals (e.g. 
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taxol, artemisinin etc.) or crude extracts (single or 
combinations) for the treatment of various diseases.  The 
easy availability, few side effects and low cost make 
herbal preparations key players from all available 
therapies, especially in rural areas (Arya et al., 2011; 
Medagama and Bandara, 2014). 
Through the years, several plants has been 
considered as a natural source of potent anti-diabetic 
drugs playing a key role in the management of diabetes 
mellitus. It is suggested that they have a promising future 
in diabetic prevention and treatment due to integrated 
effects (Singh et al., 2011). Several species of herbs 
literature as having antidiabetic activity. Ethnobotanical 
information indicates that more than 1000 plant species 
are used as traditional remedies for the treatment of 
diabetes and these traditional medicines when verified 
scientifically provided a number of promising drugs for 
new antidiabetic agents (Alarcon-Aguilar et al., 2008; 
Upendra Rao et al., 2010; Pandhare et al., 2012). But, 
further studies about efficacy, precise mechanisms of 
action and safety of herbal extract use need to be 
developed.  
 Several plant-derived products are used in 
alternative medicine for the diabetes management being 
their biological action related to their chemical 
composition. The main compounds responsible for these 
and coumarins (Upendra Rao and others 2010; Singh and 
others 2011). At times the observed clinical activity has 
also been ascribed to group of phytochemicals displaying 
synergy. Thus, a single antidiabetic herb with thousands 
of phytochemicals may have multiple benefits by 
targeting several metabolic pathways (Chang et al., 
2013). 
Smallanthus sonchifolius  
Yacon (Smallanthus sonchifolius [Poepp. & 
Endl.] H. Robinson) is an Andean crop which belongs to 
the family Compositae (Asteraceae) (Grau and Rea 
1997). Yacon and related plants were originally 
classified under the genus Polymnia (Asteraceae, 
Heliantheae, Melampodinae) (Wells 1965; Ohyama et 
al., 1990; Asami et al., 1989). However Robinson in 
1978 determined that many species of Polymnia genus, 
including the yacón, actually belongs to the genus 
Smallanthus. The new classification, S. sonchifolius 
(Poepp. & Endl.), is currently preferred while the old 
name Polymnia sonchifolia Poepp. & Endl. is considered 
as synonymous (Grau and Rea 1997; Valentová and 
Ulrichová 2003). Common names used in different parts 
of the Andes are yacon, llacón, aricoma, jicama and 
some derivatives as llaqon, llacum, llacuma, yacumpi, 
aricuma, chicama, jíquima and jiquimilla (Grau and Rea 
1997; Seminario et al., 2003). 
There are records of the use of yacón centuries 
before the Incas (NRC, 1989). The oldest yacon 
representation has been found in archaeological reserve 
Nazca (500–1200 A.C.) (Grau and Rea, 1997). 
Smallanthus sensu Robinson includes at least 21 
species, all American, ranging mostly through southern 
Mexico, Central America to northwestern Argentina. 
From the Andes, yacon was transferred in the 20th 
century through the New Zealand to Japan (Tsukihashi et 
al.,1989). Its cultivation was successfully introduced into 
Italy, Germany, France and USA though yacon is still 
not remarkably diffused there. In 1993, it was introduced 
into the Czech Republic in the form of caudices 
originating from New Zealand (Valentová et al., 2001). 
More recently, it has also been introduced into Russia 
(Tyukavin 2002). Among the South American species, 
some have been grouped into what is known as "yacon 
group" comprising 7 species with similar morphological 
characteristics: S. sonchifolius; S. macroscyphus, S. 
connatus, S. riparius, S. suffruticosus, S. meridensis and 
S. siegesbeckius (Grau and Rea 1997). 
The species S. sonchifolius; are perennial herbs, 
less frequently shrubs or small trees and only rarely 
annuals. Yacon grows up to 1.5-3 m tall (Figure 1A, B).  
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Figure 1. Smallanthus sonchifolius [Poepp. & Endl.] H. Robinson (yacon). A: Plant height. B: Aerial parts of the ya-
con plant C: Storage roots and rhizome D: Leaves. E: Glandular trichomes. F: yacon Inflorescence. From Grau and 
Rea, 1997; Cabrera WM, 2013. Doctoral Thesis. 
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The plant is extremely hard and grows in warm, 
temperate Andean valleys, but can be found at the 
altitudes of 880 to 3500 m. In most cases, just a few 
plants are cultivated for family consumption (Zardini 
1991; Hermann et al., 1999).The plant produces large 
tuberous roots similar to sweet potatoes in appearance, 
but they have a much sweeter taste and crunchy fresh 
and have cylindrical and fistulous stems at maturity 
(Figure 1C). Yacon has large crossed opposite leaves, 
simple, ovate to ovate-lanceolate, apex acuminate, base 
truncated sagital and jagged-serrated margin (Figure 1D). 
Winged petiole presents overlapping stipules, often 
connate at the leaf base. The average size is 17 cm long x 
13.7 cm lat in the middle part of the blade and 17.2 cm in 
the basal region. 
Trichomes and glands are present in the lower 
and upper epidermis with a spherical morphology as a 
result of accumulation of secretory products when they 
reach the stage of maturity (Figure 1E). The trichomes 
are involved in the synthesis of various chemical 
compounds that are very important in the interactions of 
the plant and in adaptation to biotic and abiotic factors 
(Valkama et al., 2003; Wagner et al., 2004). 
Like the sunflower, the yacon presents 
distributed big leaves of to even along very little ramified 
shafts. It represents the typical inflorescence –grouping 
of yellow-orange flowers, 3 cm in size– in a called 
structure chapter (Figure 1F). 
Chemical constituents 
S. sonchifolius, leaves consists of a variety of 
chemical compounds. The first report of yacon 
composition includes the isolation of four kaurenoids and 
four sesquiterpene lactones from the leaves (Kakuta et 
al., 1992). Other majority constituents present in yacon 
leaves were catechol, terpenes and flavonoids (Valentová 
et al., 2001). 
Valentova et al.,(2003) extracted  dried leaves 
in several ways determining two fractions (ethyl acetate 
and OF9 fraction) with high content of phenolic 
compounds. The compounds were identified as 
protocatechuic, chlorogenic, caffeic and ferulic (traces) 
acids by RP-HPLC. The presence of large amounts of 
phenolic compounds such as protocatechuic, rosmarinic, 
gallic, vanillico and gentisic, caffeic acids and their 
derivatives were also confirmed by HPLC coupled with 
electrochemical detection (HPLC-ECD) (Jirovsky et al., 
2003, Jandera et al., 2005, Valentova et al., 2005; Terada 
et al., 2009). Ferulic acid, three isomers of 
dicaffeoylquinic acids (Mr = 516), an unknown 
derivative of chlorogenic acid (Mr = 562) and an equally 
unknown flavonoid were reported for the first time by 
Simonovska et al., (2003) as constituents of yacon 
leaves. Recently, Genta and others (2010)  have 
identifyed by IR spectrum, TLC and HPLC three 
isomeric dicaffeoylquinic acids such as 3,4-
dicaffeoylquinic, 3,5-dicaffeoylquinic and 4,5-
dicaffeoylquinic as the major constituents of differents 
yacon leaves extracts Genta et al., (2010) (Figure 2). 
Interestingly, ethanol extracts and decoction 
extracts of five landraces of S. sonchifolius revealed the 
presence of higher amount of flavonoids, as luteolin 3′,7-
O-diglucoside and luteolin 7-O-glucoside together with 
apigenin and luteolin (Russo et al., 2014). 
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Figure 2. Major chemical constituents present in yacon 
leaves decoction. Caffeic acid (1), chlorogenic acid (2) 
and three dicaffeoylquinic acids: 3,4-dicaffeoylquinic (3); 
3,5-dicaffeoylquinic (4)¸ 4,5-dicaffeoylquinic (5) and the 
sesquiterpene lactone enhydrin (6). Original. 
  
Kakuta and others (1992) determined in the 
methanol extract of yacon leaves the presence of 
entkaurenoic acid and related diterpenoid substances (ent
-kaur-16-en-19-oic acid 15-angeloyloxy ester, 18-
angeloyloxy-ent-kaur-16-en-19-oic acid and 15-
angeloyloxy-ent-kauren-19-oic acid 16-epoxide. The 
authors suggested that these compounds probably play a 
certain physiological role in the defense mechanisms of 
this plant and it is highly pest-resistant. In the damaged 
leaves of yacon, Hashidoko et al., (1993, 1994) found 4-
hydroxystyrene and 3,4-dihydroxystyrene that were 
probably formed by oxidative decarboxylation of p-
coumaric and caffeic acids by enzymatic systems of 
epiphytic bacteria. Twelve novel diterpenoids: were 
found by Dou et al.,2008; 2010; Ragasa et al.,2008; Qiu 
et al.,2008; Raga et al.,2010; Zheng et al., 2010).  
Dou et al., (2008) determined the presence of 
Smallanthaditerpenic acids A, B, C and D in yacon 
leaves together with the presence of chlorogenic and 
caffeic acid. Recently, two new acyclic diterpenes 
derived from geranylnerol smallanthaditerpenic acids E 
and F were isolated by Mercado et al., (2010). 
Significant variations in leaf phenolics content could be 
determined in plants cultivated in different places and 
collected in different times of the year (Valentová et al., 
2006, Xiang et al., 2010). 
Phytochemical studies of yacon leaves also 
showed the presence of several melampolide-type 
sesquiterpene lactones such as sonchifolin, uvedalin, 
enhydrin, fluctuanin (Inoue et al., 1995, Lin et al., 2003, 
Schorr et al., 2007, Hong et al., 2008). These substances 
are also contained in other Smallanthus species, e.g. S. 
uvedalia, S. fruticosus and S. maculatus, as well as 
species from the genus Melampodium  (Asteraceae), 
which has given the name to these compounds 
(Bohlmann et al., 1980; 1984; Castro et al., 1989). Six 
new lactones were identified recently propionate and 
butirate analogs of sonchifolin, tiglate analog on C8 of 
polymatin B, fluctuadin, polymatin C and the aldheyde 
derivative on C14 of uvedalin (Mercado et al., 2010). 
Among these lactones, enhydrin is the most 
abundant one isolated from yacon leaves (Schorr and Da 
Costa 2005). It was suggested that this compound comes 
presumably from intact glandular trichomes of yacon 
leaves, given that the sesquiterpene lactones are 
produced and stored in these numerous Asteraceae 
epidermal structures (Mercado et al., 2006; Lopes et al., 
2013). While most of the methods concerning the 
quantification of sesquiterpene lactones are focused on 
the preparation of extracts from powdered plant material, 
Schorr and Da Costa (2005) evaluated the enhydrin 
content in diverse leaf rinse extracts as well as in foliar 
glandular trichomes of intact leaves. Such an approach 
can be used as a procedure in chemical quality control of 
S. sonchifolius or its derived preparations. GC–MS 
analysis of similar preparations showed 94.1% enhydrin 
and 5.9% uvedalin (Genta et al., 2010). A wide range of 
essential oils such as beta-pinene, caryophylene, y-
cadinene, β-phellandrene, β-cubebene, β-caryophyllene 
and β-bourbonene has been reported from leaves and its 
relative content was important for specification of yacon 
varieties (Adam et al., 2005; Li et al., 2009).  
Antidiabetic activity 
Yacon leaves have been used for centuries by 
the original inhabitants from the Andes valley as 
tradicional folk medicine to treat cronic diseases 
(Kakihara et al., 1997). In Japan, yacon leaves are used 
alone or in combination with common tea leaves to 
prepare medicinal infusion. In a first attempt to 
scientifically validate its use, Volpato et al., (1997) 
suggest  that yacon leaves can reduce blood glucose 
levels. In the past decade scientific evidence for the 
antidiabetic activity of the water extract of yacon leaves 
leaves in an experimental model of diabetes induced by 
STZ in rats was done (Aybar et al., 2001). Streptozotocin 
(STZ) injection in rats has been described as a good 
experimental model to study the effects of drugs on 
diabetes and some changes occurring in this state. In this 
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model there is destruction of the β-cells of the islet of 
Langerhans of the pancreas (Lenzen et al., 2008). The 
results showed that the intraperitoneal administration of 
STZ effectively induced diabetes in normal non-fasted 
rats in a dose depended manner. This was reflected by 
glycosuria, high glycemia, polyphagia, polydypsia and 
body weight loss compared with normal control rats. The 
administration of 2% yacon tea and 10% yacón 
decoction for a 30 day period significantly inhibited the 
hyperglycemic action of STZ. Diabetic manifestations in 
yacon- treated rats were reduced as revealed by clinical 
parameters. Interestingly, lipid profile of diabetic 
animals was improved and the altered creatinine and 
albumin concentrations were normalized (Aybar et al., 
2001; Honoré et al., 2012). Moreover, yacon decoction 
proved to have a hypoglycemic effect on healthy, 
transiently hyperglycemic and diabetic rats, a fact that 
led to suppose that a certain pancreatic activity was 
necessary for such an effect to occur. Yacon decoction 
also caused a significant decrease in the hyperglycemic 
peak during the glucose tolerance test which was fairly 
comparable to that of glymepiride.  
Thereafter, similar results were reported by 
Baroni et al., (2008) using crude extracts of yacon leaves 
obtained by hot or cold aqueous extraction or hydro-
ethanolic preparation. Yacon leaf extracts have also 
shown hypoglycemic activity on KK-Ay mice, which 
suffer from genetically induced diabetes and in alloxan 
diabetic mice (Miura et al., 2004, Miura 2007; Raga et 
al., 2010). Furthermore, a clinical study has shown that 
ingestion of yacon leaf and stem powder was effective to 
reduce post-prandial peak of glucose in humans (Ogose 
et al., 2006).  
The bioactivity screening of five organic 
extracts of yacon leaves provided an effective guide for 
the identification of the most active hypoglycaemic 
compounds. The methanol, butanol and chloroform 
extracts were found to have an effective hypoglycemic 
activity at minimum doses of 50, 10 and 20 mg/kg body 
weight, respectively. Oral administration of a single-dose 
of each extract produced a slight lowering effect in the 
fasting blood glucose level of normal healthy rats, 
whereas each extract tempered significantly the 
hyperglycemic peak after food ingestion. Moreover, 
Genta and others 2010 observed that daily administration 
of different extracts of yacón leaves during 8 weeks 
produced an effective glycemic control in diabetic 
animals with an increase in the plasma insulin level. 
These results were in concordance with previous in vitro 
studies where organic fractions and aqueous extracts 
from S. sonchifolius leaves reduced glucose production 
via gluconeogenesis and glycogenolysis pathways in rat 
hepatocytes (Valentová et al., 2004). The phytochemical 
analysis of the most active fraction the butanol extract, 
revealed that caffeic, chlorogenic and three 
dicaffeoilquinic acids were significant components 
(Genta et al., 2010) (Figure 2). These chemical 
compounds have been involved as active principles in 
glucose metabolism regulation (Nicasio et al.,2005; Jung 
et al., 2006). Thus, caffeic acid produced a marked 
plasma glucose-lowering effect in diabetic rats (Hsu et 
al., 2000) while chlorogenic acid improved glucose 
tolerance and insulin resistance in obese (fa/fa) Zucker 
rats (Rodríguez de Sotillo et al., 2002, Ong et al., 2013).  
Additionally, enhydrin, the major sesquiterpene 
lactone of yacon leaves (Figure 2), was found effective 
to reduce post-prandial glucose and useful in the 
treatment of diabetic animals (minimum dose: 0.8 mg/kg 
body weight). These results validated for the first time 
the antidiabetic effect of this sesquiterpene constituent 
(Genta et al., 2010). However the hypoglycemic effect 
had previously been suggested together with a number of 
biological activities (Hwang et al., 1996; Kawashima et 
al., 2001). During the last few years, some new 
compounds isolated from yacon leaves were proved to be 
also responsible of the anti-diabetic properties in alloxan-
induced diabetic mice (Raga et al., 2010). 
Recently Ogose et al., (2009) examined the 
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inhibitory effect of a single ingestion of a test food which 
consisted in leaves and stem extract on postprandial  
blood glucose in subjects with normal blood glucose or 
borderline diabetes suggesting that a diet containing 
yacon would be useful for diabetes prevention. 
Hipoglycemic and anti-hiper glycaemic activities 
The most important goal in the management of 
diabetic patients is to maintain blood glucose level as 
close to normal as possible (Mooradian and Thurman 
1999). In addition, postprandial hyperglycemia or 
hyperinsulinemia are independent risk factors for the 
development of macrovascular complications of diabetes 
mellitus (Kim et al., 2000). There are several possibility 
for the mechanisms by which the plant reduces blood 
glucose concentration: reduction of the intestinal 
absorption of glucose, increase in glucose uptake by 
tissues and organs, increased release of insulin through 
stimulation of the β-pancreatic cells, resistance to the 
hormones that increase the rate of glucose release, 
increase of the number and sensitivity of the insulin 
receptors and decreased release glycogen degradation, 
among others (Negri 2005). 
Aquous extracts of S. sonchifollius leaves 
administered by 30 days were found to significantly 
increase  circulating insulin levels and decreased blood 
glucose level in STZ-diabetic rats (Aybar et al., 2001, 
Honoré et al., 2012). So, leaf phytochemical leaves 
compounds, responsible for its hypoglycemic activity 
may have the ability to increase the number of β-cells, 
stimulate insulin synthesis/release from pancreatic β-
cells, inhibit insulin degradation or of both. 
Inmunohistochemical procedure showed that the amount 
of insulin secreating β-cells of the islets of Langerhans is 
greater in yacon treated-diabetic rats in comparison to 
control group suggesting that yacon also have the 
potential to protect it from STZ-induced damage in 
experimental animals (Honoré et al., 2012) (Figure 3). 
Enhidryn were also found to increase the number of β-
cells and insulin mRNA levels in pancreatic islets of STZ
-diabetic rats (Serra Barcellona et al., 2014).  
In addition, an insulin-like effect of yacón 
leaves extracts has been reported in FAO cells, a 
hepatoma cell line, which not requires specific insulin 
supplementation of the culture medium (de Waziers and 
others 1995; Valentova et al.,2004). Using this model, 
Valentova et al., (2005) showed that differtent organic 
Honoré et al., 2015              
008                          Journal of Research in Biology (2015) 5(A): 001-022                                                                                                                                
Figure 3. Effects of 10% yacon decoction on insulin. A: Immunofluorescence 
staining of insulin in the pancreas. Representative histological sections of pan-
creatic islets of control, yacon-control, STZ and STZ-yacon rats incubated with 
anti-insulin antibody. Bars: 50µm. B: Quantitative analysis of insulin positive 
area. Data expressed as means ± DE, (p<0.05, n=10). C: Fasting plasma insulin 
levels. Data expressed as means ± DE, (p<0.05, n=10). From Honoré and others 
2012. Food and Chemical Toxicology 50:1704-1715. 
  
extracts of S. Sonchifollius were able to down-regulated 
CYP2E  and cytochrome CYP2B mRNA expression 
similarly to insulin. 
In that sense, it has been proposed that 
antidiabetic effect of S. sonchifollius observed in vivo is 
probably due not only due to its effects on plasma insulin 
concentration, but also, to a specific action on hepatic 
metabolism. Valentova et al., (2005), have demonstrated 
that organic yacon leaf extracts were able to reduce 
glucose production in hepatocyte  primary cultures by 
inhibition of gluconeogenesis and glycogenolysis 
pathways.  
Also, Baroni et al., (2014) demonstrated that 
diabetic rats treated with yacon extracts presented a 
significant improvement in the glucose-6-phosphate 
dehydrogenase (G-6-PDH) activity. Furthermore, it was 
observed that yacon treatment increased the hepatic and 
muscle glycogen content and caused a reduction in 
hepatic Aspartate Aminotransferase  (AST) activity in 
diabetic rats. 
Probably these effects could be due to the 
presence of polyphenolics compounds as chlorogenic 
acid and its derivatives in yacon leaves, which, has been 
shown to be competitive inhibitors of glucose-6-
phosphatase reducing glucose production in isolated 
perfused rat liver (Arion et al., 1997; Hemmerle et al., 
1997). 
Several reports have mentioned that many 
phytochemical compounds may also act as hypoglycemic 
by delaying the transfer of glucose from the stomach to 
the small intestine, the main site of glucose absorption 
and by inhibiting the glucose transport at the site of 
intestinal brush border membranes (Tiwari and Rao 
2002). 
In this context, Matsuura et al., (2004) analyzed 
the inhibitory effects on the intestinal digestion and 
absortion of sugar of Japanese commercial health teas, 
including yacon. However, the authors observed no 
significant changes in portal plasma glucose 
concentration after administration of health teas during 
continuous intragastric infusion of sucrose.  
Polyphenolics derived from aqueous extracts 
have been reported to inhibit a-amylase and sucrase, and 
have been shown to be the principle substance for 
suppressing postprandial hyperglycemia. Furthermore, 
these polyphenolics also inhibit glucose transport across 
the intestine by inhibiting sodium glucose co-transporter 
(S-GLUT-1) (Kobayashi et al., 2000). Oboh and others 
(2015) provided evidence that both caffeic and 
chlorogenic acid derivatives identified in extracts from 
yacon leaves inhibited α-amylase and α-glucosidase 
activities in a dose-dependent manner. Moreover, the 
esterification of caffeic acid with quinic acid, producing 
chlorogenic acid, reduces their ability to inhibit α-
amylase and a-glucosidase activities. In a previous study 
another phenolic component from yacon leaves, the 
tricaffeoylaldaric acid, has been demonstrated to have 
strong antioxidant and α-glucosidase activity (Terada et 
al., 2009). 
In vivo and in vitro studies in normal and 
diabetic rats showed that the sesquiterpenic lactone 
enhydrin has an inhibitory effect on α-glucosidase 
activity in a dose-dependent manner (Serra Barcellona et 
al., 2010). Also, Xiang et al., (2010) observed the same 
inhibitory effect of smallanthaditerpenic acids A, B, C 
and D isolated from yacon leaves, all of which may 
account for the effective capacity of the leaves to 
attenuate intestinal glucose absorption. 
Antioxidant activity 
Oxidative stress has been linked to the 
development of most chronic diseases (Valko et al., 
2007; Chang and Chuang 2010). Specifically, in 
diabetes, it is thought to play a role in both pathogenesis 
and course of the disease (Baynes 1991; Chang and 
Chuang 2010). Diabetes creates a condition conducive 
for the promotion of oxidative stress, and in turn free 
radicals produced in excess from glucose auto-oxidation 
and protein glycation with a simultaneous decline of the 
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antioxidant defense system that mediate some of the 
harmful effects of hyperglycemia, which manifest as 
complications of the disease (King and Loeken 2004, 
Giacco and Brownlee 2010). Much scientific evidence 
revealed  that antioxidant defense system represents a 
complex network with interactions, synergy and specific 
tasks for a given antioxidant. So, effort to find suitable 
antidiabetic and antioxidant therapy are necessary.  
The leaves of yacon have high content of 
phenolic compounds, recognized for their ability to 
capture free radicals. Thus, the presence of 
protocatechuic, chlorogenic, caffeic  and ferulic acids in 
the two fractions extracted from S. sonchifolius leaves 
showed potent antioxidant activity in 1,1-diphenyl-2-
picrylhydrazyl and xanthine/XOD superoxide radical 
scavenging tests, they inhibited the lipoperoxidation of 
rat liver subcellular membranes and they protected rat 
hepatocytes against oxidative injury (Valentovà et al., 
2003; 2004; 2005). Hot water extract of the aerial part of 
yacon also showed potent free radical-scavenging 
activity and inhibitory effects on lipid peroxidation in rat 
brain homogenate, being 2,3,5-tricaffeoylaltraric acid the 
major component in the fraction (Terada et al., 2006).  
As was mentioned above, Baroni et al., (2014) 
demonstrated in vivo that hydroethanolic extracts of S. 
sonchifolius improved the activity of G-6-PDH. 
Increased expression of this enzyme has been associated 
with increased glutathione levels and resistance to 
oxidative stress (Oberley 1988). Previous reports have 
indicated that the NADPH produced by G-6-PDH 
participates in the elimination of reactive oxygen species 
via glutathione peroxidase and catalase in both hepatic 
and extrahepatic tissues (Salvemini et al., 1999). 
Preliminary studies confirmed the strong 
antioxidant potential of yacón leaves and the isolated 
compound enhydrin of in normal and diabetic rats (Serra 
Barcellona et al., 2012a). 
Renal protective effect 
Diabetic nephropathy is considered as the most 
common cause of renal damage and is the major 
microvascular complication in long-standing patients of 
both type 1 and type 2 diabetes mellitus, leading to end-
stage renal disease (Schrijvers et al., 2004; Kanwar et al., 
2008). Pathological changes such as expansion of 
mesangial cells, accumulation of extracellular matrix 
proteins, thickening of glomerular and tubular basement 
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Figure 4. Effects of 10% yacon decoction on ultrastructural changes in 
diabetic kidney. Glomerular ultrastructure and tubulointerstitial ultra-
structure of control, STZ and STZ-yacon rats. Segmental thickness of 
glomerular basement membrane and excessively deposited tubulointer-
stitial matrix were observed. Yacon decoction treatment improved STZ
-induced renal ultrastructural abnormalities. Bm: Basement membrane; 
Pc: podocyte; Mi: mitochondria; Cap: capillary. Bars: (A) 0.8µm; (B-
C) 50µm. From Honoré and others 2012. Food and Chemical Toxicol-
ogy 50:1704-1715. 
  
membranes, tubulointerstitial fibrosis, glomerulosclerosis 
and renal endothelial dysfunction occur in the diabetic 
kidney (Kanwar et al., 2008). For this reason, in the last 
years has intensified the search for new therapeutic 
agents that can prevent the onset of nephropathy or delay 
the progression of glomerulosclerosis. 
 
 A number of studies have now definitely proved 
that improved metabolic control that achieves near-
normoglycemia can significantly decrease the 
development and progression of diabetic nephropathy 
and the early identification of microalbuminuria is 
considered to be clinically relevant (Gomes et al., 1997). 
Aybar et al., (2001) showed that yacon tea treatment 
improves the general condition of diabetic rats and tends 
to restore certain normal  renal parameters. Honoré et al., 
(2012) demonstrated an effective renoprotective action 
of 10% yacon decoction. Indeed, the treatment for 4 
weeks of attenuated diabetes induced renal dysfunction 
by reducing mesangial matrix expansion, 
tubulointerstitial fibrosis and tubular atrophia in diabetic 
rat (Figure 4). These findings were correlated with down-
regulated expression of TGF-β 1/Smad signaling, a 
cytokines involved in kidney fibroblast activation and 
proliferation (Balakumar et al., 2009; Liu 2011). In fact, 
in this study, yacon treatment down-regulated Smad2/3 
phosphorylation blocking TGF-β signaling, particularly 
in areas where severe tubulointerstitial fibrosis had been 
observed. Moreover, Serra Barcelona et al., (2012) 
showed that yacon leaves decoction had an important in 
vivo antioxidant activity in the kidney of diabetic rats, 
protecting cells from lipid peroxidation slowing down 
the progression of early diabetic nephropathy. 
 
Other pharmacological activities 
Anti microbial activity 
The newly identifed compound, 8b-
tigloyloxymelampolid-14-oic acid methyl ester isolated 
from yacon leaves, exhibited a potent antimicrobial 
activity against Bacillus subtilis and antifungal activity 
against Pyricularia oryzae. Also, fluctuanin exhibited the 
strongest antibacterial activity against B. subtilis among 
six identified sesquiterpene lactones present in the yacón 
leaves extract (Lin et al 2003). In addition, different 
aquous and organic extracts of yacon leaves have 
demonstrated antimicrobial activity against Methicillin-
resistant Staphylococcus aureus (Joung et al., 2010). 
Furthermore, Choi et al., (2010) showed that enhydrin 
can be considered as an antibacterial compound against 
against 2 strains of Methicillin-resistant Staphylococcus 
aureus ATCC 33591, ATCC 25923. 
Anti parasitary activity 
In a recent work, the trypanocidal activity of the 
species S. sonchifolius has been evaluated by in vitro 
assays (Frank et al., 2013). Dichloromethane extract of  
the leaves induced a significant growth inhibition when 
tested against Trypanosoma cruzi epimastigotes. 
Through chromatographic separations of the more active 
fractions, the authors have isolated three structurally 
related germacranolide melampolide-type sesquiterpene 
lactones, which were identified as enhydrin, uvedalin, 
and polymatin B. According to the results, enhydrin and 
uvedalin might have potential as agents against Chagas 
disease and could serve as lead molecules to develop 
new drugs (Fabian et al., 2013). 
Anti inflammatory activity 
Two new melampolide-type sesquiterpene 
lactones, 8b -epoxyangeloyloxy-9a-ethoxy-14-oxo-
acanthospermolide and 8b -angeloyloxy-9a-ethoxy-14-
oxo-acanthospermolide, together with eleven known 
lactones isolated from yacon leaves shown to inhibit 
nitric oxide (NO) production in LPS-stimulated murine 
macrophage RAW 264.7 cells (Hong et al., 2008). This 
action is interesting since, NO is involved in 
physiological and pathological process, such as 
vasodilation and chronic or acute inflammation (Hobbs 
et al., 1999). 
On the other hand, yacon leaf rinse extract 
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exhibited topical antiedematous activity in vivo. This 
activity may be a consequence of an anti-inflammatory 
action, as evidenced by neutrophil migration inhibition, 
and NO, TNF-α and PGE2 inhibition.The authors also 
showed that both sesquiterpene lactones and chlorogenic 
acid derivatives contribute to the anti-inflammatory 
action, suggesting that yacon leaves could have a 
potential use as topical anti-inflammatory agent (Oliveira 
et al., 2013) 
Anti cancer activity 
The sesquiterpenic lactones isolated from yacon 
leaves enhydrin, uvedalin and sonchifolin caused 
cytotoxicity to HeLa cells through induction of apoptosis 
(Siriwan et al., 2011). These authors have been 
demonstrated for the first time, that yacon sesquiterpenic 
lactones can induce apoptosis via increased activation of 
caspase-3/7. These finding were supported with the 
evidence of morphological analysis, lactate 
dehydrogenase release and DNA synthesis inhibition. 
Furthermore, sesquiterpenic lactones can inhibit the 
activation of NF-κB binding protein. Interestingly, 
enhydrin may possibly have another mechanism of high 
anti-cervical cancer activity because caspase-3/7 activity 
was lower than uvedalin and sonchifolin even though its 
cytotoxicity showed the greatest values. These new 
findings may offer information for further development 
of new chemotherapeutic agents or its analogs for 
cervical cancer therapy. 
Other biological effects 
 Mycotoxins are probably the best known and 
most intensively researched in the world. Particularly, 
aflatoxins are toxic metabolites produced by certain 
fungi in/on foods and feeds and have been associated 
with various diseases in human beings and domestic 
animals (Eaton and Groopman 1994). Aqueous extract 
and isolated compounds from Polymnia sonchifolia 
leaves have found to inhibit Aspergillus flavus growth 
and production of aflatoxin B1 (Pinto and others 2001; 
Gonçalez et al., 2003, Fernandes et al., 2005; Pak et al., 
2006). Whereby, yacon can be used as an alternative 
method in the chemical control of mycotoxin production. 
Safety 
Despite the traditional use of decoction yacon 
leaves, in the literature there are few studies that evaluate 
the toxic potential of both yacon leaves extract and pure 
compounds (de Oliveira et al., 2011; Fernandes et al., 
2005; Genta et al., 2010; Ogose et al., 2009; Siriwan et 
al., 2011). 
The degree of side effects or toxicity presented 
by extracts or compounds of medicinal plants depends on 
many complex factors. The effects of a single large dose 
of a toxic substance may not necessarily reflect the risks 
associated with the long- term low-level consumption 
commonly used in folk medicine. In addition, long-term 
studies are essential to determine a range of bioactivities 
to a no-observed-adverse-effect level (NOAEL) (Serra 
Barcellona and others, 2012b; Alexeeff et al.,2002). 
The safety of yacón consumption was evaluated 
at first time in an acute toxicity test. Normal healthy rats 
treated with 2, 5, 10 times greater than the effective dose 
of different organic extract of yacón leaves or isolated 
compund enhydrin, evidenced no deaths or noticeable 
signs of acute toxicity. (Genta et al., 2010; 2012). 
Moreover, Ogose et al., (2009) judged that the 
administration of yacon extracts to rats for two 
generations had no effects on either the reproductive 
functions or the development of the liveborn pups.  
A recent acute toxicity experiment  tested a 
specific range of doses of the 10% yacon leaves 
decoction (25, 50 and 100 times) and enhydrin (100, 200 
and 400 times) for the effective hypoglycaemic dose. Up 
to 14 days of administration no signs of toxicity or 
deaths were recorded suggesting that the LD50 of the 
10% decoction and of enhydrin would be above 14.0 and 
0.32 g/kg bw, respectively (Serra Barcellona et al., 
2012b). These values were significantly higher than the 
effective hypoglycaemic doses (Aybar et al., 2001; 
Honoré et al., 2012). Also 10% decoction orally 
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administered were found non toxic, at least up to the 
maximum level assayed (0.28 g/kg bw/day). Similarly, 
isolated enhydrin had no toxic effects at a dose range of 
0.4 to 8.0 mg/kg bw/day (Serra Barcellona and others 
2012b). 
The beneficial effects associated with the 
consumption of organic or aqueous extracts of yacon 
leaves for long periods might suggest that they have a 
high safety margin (Valentova et al, 2003, 2005; Genta 
et al., 2010; Honoré et al., 2012; Serra Barcellona et al., 
2012b). However, de Oliveira et al., (2011) showed that 
prolonged oral administration (90 days) of 2% of yacon 
leaves infusion and a leaf rinse extract was associated 
with kidney damage and attributed it to the presence of 
sesquiterpene lactones and flavonoids as 3-O-
methylquercetyn in the extract. Such differences could 
be related to the the differences in the phytochemical 
preparations analyzed by both groups. Moreover, it is 
well known that chemical composition of yacon leaves 
could present significant differences among the studied 
landraces and different times of the year collection 
(Russo et al., 2010; Xiang et al., 2010). 
In vitro cytotoxicity assays were performed with 
a selection of different cell lines based in the main target 
organs. Cytotoxicity study based in metabolic 
competence assay, showed a concentration-dependent 
decrease in mitochondrial function and consequently in 
cell viability. COS1 cells were the most resistant to the 
treatment with both 10% yacon decoction or enhydrin 
and the normal epithelial Vero cells showed intermediate 
values of IC50, very similar to epithelial-like CHO-K1 
cell line, evidencing the different response to potential 
adverse or toxic effects of the extracts or pure compound 
under investigation (Serra Barcellona et al., 2012b). 
However it is interesting  to mention that in vivo toxicity 
studies unlike the in vitro assays, the effects of an oral 
dose are subject to systemic bioavailability and hepatic 
metabolism, pharmacokinetic processes that are absent in 
a cell culture model (Singh, 2006). 
Conclusion 
S. sonchifollius, popularly known as yacón, is 
the species among all Andean food plants which is that is 
the most likely to attract worldwide attention in the near 
future because of its wide range of uses. 
Different aqueous and organic extracts or even 
isolated biomolecules from yacon leaves have been 
tested for their antidiabetic properties using both in vivo 
and in vitro approaches and were reviewed here. Some of 
these compounds show promising effects, indicating that 
dietary intake of phytochemicals present in yacon leaves 
could be a promising strategy for the management of 
diabetes. 
The combination of radical scavenging, 
cytoprotective and antihyperglycemic  activity makes S. 
sonchifollius leaves a good candidate for preventing or 
treating chronic disease involving oxidative stress. 
Additionally, toxicity studies of S. sonchifollius extract 
and isolated compounds have demonstrated their safety 
when taken in recommended doses. 
Therapies based on yacon phytochemicals could 
constitute a novel pharmacological approach that would 
reinforce existing treatments. 
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